Submit your Defective Drugs claim details for a free, no obligation case review.
Get Started:
drug_recall accutaneFamilies of suicide victims have filed the majority of Accutane lawsuits. When Accutane was first approved, Hoffmann-LaRoche did not market it because of the high risk of birth defects. The Accutane lawsuits that have been filed over the years continue to raise questions about the regulation of Accutane and its safety.
Some Accutane lawsuits have accused Hoffman-La Roche of failing to perform an adequate investigation during clinical trials to see if a link for suicide existed. Even though the FDA required Roche to add suicide as a potentially rare side effect of Accutane in 1998, some Accutane lawsuits have alleged that the company downplayed the extent of the dangers.
Rep. Stupak and some other lawmakers have been aggressive, stressing that there still fails to be any thorough studies investigating the link between Accutane and suicide. Although, in 1997, a French study of Accutane''s association with depression, led to the French health authorities to require "suicide attempt" be added to Accutane''s side effects.
Accutane lawsuits alleging Hoffmann-La Roche was not forthright with information includes the May 1997 discussion the FDA initiated with Roche regarding reports of serious psychiatric disorders amongst Accutane users. Accutane lawsuits point out the FDA was not aware of the French warning.
Thirty-six-year-old Andrew McCarrell of Moody, Alabama was awarded $119,000 for his past medical expenses and $2.5 million in compensatory damages to cover his future medical costs and for pain and suffering in a jury verdict awarded yesterday. His law...
A new study warns that approximately one in three patients who took the acne drug Accutane experienced a rise in cholesterol levels and more than 40 percent showed increased levels of triglycerides, or blood fats—a higher percentage than what previous ...
Ever since Accutane made its 1982 U.S. debut, intended to treat severe forms of acne that failed to respond to other treatments, it has been the source of medical and regulatory controversy. Now, a Florida lawsuit against Accutane drugmaker Hoffmann-L...